22930-75-2

Usage

Uses

Used in Pharmaceutical Industry:
3-METHYL-1H-PYRROLO[3,2-C]PYRIDINE is used as a building block for the synthesis of various drugs and bioactive molecules due to its unique molecular structure and potential medicinal properties.
Used in Medicinal Research:
3-METHYL-1H-PYRROLO[3,2-C]PYRIDINE is used as a subject of study for its antiviral and anti-tumor effects, indicating its potential as a therapeutic agent in the treatment of viral infections and cancer.
Used in Organic Synthesis:
3-METHYL-1H-PYRROLO[3,2-C]PYRIDINE is used as a component in organic synthesis, where its heterocyclic structure can be utilized to create a variety of organic compounds for different applications.
Used in Material Science:
3-METHYL-1H-PYRROLO[3,2-C]PYRIDINE is used in material science applications, where its chemical properties may contribute to the development of new materials with specific characteristics.

Upstream product

• 868173-90-4 3-methyl-2-trimethylsilyl-1H-pyrrolo[3,2-c]pyridine 
• 88511-27-7 3-iodopyridin-4-amine 

Downstream Products

• 868173-98-2 N-[4-(3-methyl-pyrrolo[3,2-c]pyridine-1-sulfonyl)-phenyl]-acetamide 

Relevant academic research and scientific papers

TRIAZINE COMPOUND AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

The invention discloses a triazine derivative and a pharmaceutically acceptable salt, a pharmaceutical composition and use thereof. Particularly, the invention discloses a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and R4 are defined as described in the description and claims. The compound or a salt thereof according to the invention may be used for treating or preventing diseases or conditions by regulating some mutation forms of epidermal growth factor receptors. The invention also discloses a pharmaceutical composition comprising the compound or a salt thereof, and a method for treating various forms of EGFR-mediated diseases (including non-small cell lung cancer) by using the compound and a salt thereof.

5-Azatryptamine analogs as h5-HT6 serotonin receptor ligands

5-Aza analogs were prepared of several tryptamine derivatives and a skatole derivative known to bind at human 5-HT6 receptors and evaluated to determine if they bind in a manner similar to their indolic analogs. In general, the azatryptamines d

diazaindenes (azaindoles)-IV. Oxidation of 1,5- and 1,7-diazaindenes and a novel route to 3-substituted diazaindenes

Treatment of certain 1,5- and 1,7-diazaindenes with a small molar excess of hydrogen peroxide in acetic acid causes opening of the pyrrole ring with loss of the 2-C atom to give aminopyridyl ketones or aminopyridine carboxylic acids. The former have been used as intermediates in the synthesis of 3-substituted diazaindenes by reaction with dimethylsulphonium methylide. Stable iodine complexes with 1,5-diazaindenes may be formed: 6-(4-aminopyrid-3-yl)-6-oxohexanoic acid gave 4-(1-methyl-1,5-diazainden-3-yl)butanoic acid.